Charles Nemeroff :CME, when atypical antipsychotics don't work for depression, funded by AstraZeneca-Seroquel

CME Outfitters Biased CME Program

---

CME is (Continuing Medical Education) your doctors pay to learn for credit. AstraZeneca sponsored this course for antipsychotics being used for MDD- Major Depressive Disorder--and just this week the US FDA approved Seroquel for depression, in fact it is now being called an antidepressant.

Charles Nemeroff is the most conflicted researcher out there, investigated by Senator Charles Grassley for non disclosure of money received from pharmaceutical companies. Do you wonder now why your doctor is influenced by money, and corporate greed and learns from them? shouldn't the learning be separate from the drug company? AstraZeneca has its talons in the flesh of America with Seroquel, the 4+billion dollar cash cow, and you are a victim, and no longer can claim ignorance. Educate yourself and you'll be shocked at this tangled web of lies and deceipt in the name of "mental health care". (Stowe has a GSK, Paxil background that nightmares are created from)
--

Further reading from Dr. Daniel Carlat, Psychiatrist and blog author (and a little bit of CME $$)

The Carlat Psychiatry Blog:

Monday, October 12, 2009

CME Outfitters: Guilty of Pro-Seroquel Bias, According to ACCME

"Dr. Carroll had filed a formal complaint on December 23, 2008 about a web-based round-table discussion of the use of antipsychotics in depression, which was chaired by Charles Nemeroff (the disgraced psychiatrist who resigned under pressure as chair of psychiatry at Emory after the New York Times reported that he lied to the University about payments from GlaxoSmithKline, promising officials that he would limit his earnings to the required $10,000/year from promotional talks, then going on to earn $170,000 that year alone.)

Nemeroff's program was produced by CME Outfitters and was funded by Astra Zeneca, maker of Seroquel, an antipsychotic which was recently approved for add-on treatment of depression. After its investigation, according to Dr. Carroll, the ACCME determined that the program did, indeed, violate its standards."--Carlat blog

Health Care Renewal: Bernard Carroll-"As for Dr. Nemeroff, he is yesterday’s news. The adverse findings by ACCME about his program serve as a reminder to corporate sponsors and CME companies that Dr. Nemeroff is so compromised by now that he has lost effectiveness as a front man for Pharma. Indeed, he is so toxic that he now glows in the dark."